Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar immunogenicity and safety in healthy infants
NCT00276107Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2004
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 4 trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Dec 2004; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00276107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276107.